Fraunhofer Institute for Cell Therapy and Immunology IZI

We transfer biomedical research into the clinic.

The Fraunhofer Institute for Cell Therapy and Immunology IZI investigates and develops solutions to specific problems at the interfaces of medicine, life sciences and engineering. One of the institute‘s main tasks is to conduct contract research for companies, hospitals, diagnostic laboratories and research institutes operating in the field of biotechnology, pharma­ceuticals and medical engineering.

The Fraunhofer IZI develops, optimizes and validates methods, materials and products for the business units Cell and Gene Therapy, Drugs and Diagnostics. Its areas of competence lie in cell biology, immunology, drug biochemistry, bioanalytics and bioproduction as well as process development and automation. In these areas, research specifically focusses on the indications oncology, immunological diseases as well as infectious diseases and neurodegenerative diseases.

The institute works in close cooperation with hospital institutions and performs quality tests besides carrying out the GMP-compliant manufacture of clinical test samples. Furthermore, it helps partners obtain manufacturing licenses and permits.

News

Latest press releases

17.7.2020

Research team from Göttingen and Halle develops new inhibitors for enzymes

With over 1.2 million people affected in Germany alone and over 50 million people worldwide, Alzheimer's disease, also referred to simply as Alzheimer's, is one of the greatest medical and social challenges of our time. Due to pathological changes in the brain, patients become increasingly forgetful and disoriented as the disease progresses. In the worst cases, even close relatives are no longer recognized and simple household tasks can no longer be carried out independently. This means care is needed for those affected. Despite intensive research, Alzheimer's disease is still considered incurable today. Researchers at the University of Göttingen and the Fraunhofer Institute for Cell Therapy and Immunology Leipzig-Halle have described a promising approach to treating Alzheimer's disease. The results have been published in the journal Biochemistry.
Read more

8.7.2020

Prognostic biomarkers for prostate cancer identified

Led by the Fraunhofer Institute for Cell Therapy and Immunology IZI in Leipzig, as well as the Department of Urology of the University Hospital and Faculty of Medicine of the Technische Universität Dresden, a team of researchers has succeeded, for the first time, in identifying prognostic biomarkers for prostate cancer which are based on transcriptome-wide gene sequencing. The description of the developed gene signature for the assessment of prostate cancer after surgery has now been published in the renowned “European Urology” journal.
Read more

30.6.2020

Astacin Proteases Unit established at Fraunhofer IZI

On 20th May 2020, the Astacin Proteases junior working group started its work at the Fraunhofer Institute for Cell Therapy and Immunology (IZI). This group, which is headed by Dr Daniel Ramsbeck, primarily focuses on the design and development of meprin inhibitors and the development of ovastacin inhibitors. The research group will be funded by the Investitionsbank Sachsen-Anhalt (using funds from the European Regional Development Fund (ERDF)) for a period of roughly two years.
Read more

19.5.2020

Patented Fraunhofer IZI technology facilitates specific Dengue virus diagnostics

A new technology developed by the Fraunhofer Institute for Cell Therapy and Immunology (IZI) facilitates a specific, sensitive diagnosis of the Dengue virus. The patented procedure has been licensed to two companies and corresponding antibody tests are now available on the market. As a result, both the four different Dengue virus serotypes can be differentiated and also the Dengue virus itself can be distinguished from other closely related flaviviruses, which include the yellow fever virus and tick-borne encephalitis virus, in addition to the Zika virus and the West Nile virus. Moreover, work is already underway to adapt the procedure to the SARS-CoV-2 virus and the West Nile virus.
Read more

Press / media

 

As an institution of application-oriented research, the Fraunhofer Institute for Cell Therapy and Immunology IZI attaches great importance to informing customers and the public.

Events

 

The Fraunhofer IZI offers its partners and guests space for communication.

Utilize our modern and representative premises for your event. The generously proportioned and modern space offered at the Institute provides space for, e. g., workshops, symposia, conferences and lectures.

 

 

United against Corona

 

West Nile Virus on the rise in Europe

The European Centre for Disease Prevention and Control has been recording the rising spread of the virus in Europe and its neighboring countries for many years now.

 

Annual report 2019

The annual report gives you an insight into the structure of the Fraunhofer IZI, our services, important events and publications, offers, as well as selected project examples.

Research projects funded by the EU

Research projects at Fraunhofer IZI that are supported by the Land of Saxony / Saxony-Anhalt / Mecklenburg-Western Pomerania using funds provided by the European Regional Development Fund (ERDF).

 

Business units and core competencies

The Fraunhofer IZI offers R&D services for pharmaceutical, biotechnological and medical technology companies as well as for partners from research institutions, hospitals and diagnostic laboratories.

Jobs / career

We keep you informed on current job offers at the Fraunhofer IZI. Find out about the possibilities the Fraunhofer-Gesellschaft could offer you as an employer.

Publications

We gladly provide our clients and partners as well as the interested public with information on our research activities.

 

Contact

Fraunhofer IZI

 

Perlickstraße 1
04103 Leipzig
Germany

Phone +49 341 35536-1000
Fax +49 341 35536-8-1000
E-mail info@izi.fraunhofer.de

 

Social Media